Billing for Hemophilia Video
Published 09/10/2024
For providers billing for hemophilia, understanding appropriate modifiers and their accurate usage is vitally important to ensure proper payment. The JW or JZ modifiers are required to identify any discarded amounts or to attest that there are no discarded amounts of drugs from single dose containers. When applicable providers are required to report either modifier JG or TB depending on hospital type to indicate that a drug was acquired through the 340B program.
To view this video, please select one of the links below:
